SCHEMBL31632255

SCHEMBL31632255

N#Cc1ccc(-c2cc(=O)c3cc(Cl)c(N)c([N+](=O)[O-])c3o2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 2/20 0.46
▸ VCAM1 P19320 1/20 0.40
▸ CDK1 P06493 5/20 0.40
▸ CCNB1 P14635 5/20 0.40
▸ AR P10275 2/20 0.39
▸ TERT O14746 1/20 0.39
▸ CSNK2A2 P19784 2/20 0.38
▸ CSNK2B P67870 2/20 0.38
▸ CSNK2A1 P68400 2/20 0.38
▸ PARP1 P09874 1/20 0.38
▸ TNKS2 Q9H2K2 1/20 0.38
▸ PARP2 Q9UGN5 1/20 0.38
▸ MERTK Q12866 1/20 0.37
▸ GABRP O00591 2/20 0.36
▸ GABRD O14764 2/20 0.36
▸ GABRA1 P14867 2/20 0.36
▸ GABRB1 P18505 2/20 0.36
▸ GABRG2 P18507 2/20 0.36
▸ GABRB3 P28472 2/20 0.36
▸ GABRA5 P31644 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31632321 0.87 AR (0.46) TNKSCDK1CCNB1ARCSNK2A2
SCHEMBL31632272 0.85 TNKS (0.53) TNKSARTERTCSNK2A2CSNK2B
SCHEMBL31632356 0.83 TNKS (0.49) TNKSCDK1CCNB1ARTERT
SCHEMBL31632334 0.78 AR (0.46) TNKSCDK1CCNB1ARTERT
SCHEMBL31632287 0.73 TNKS (0.53) TNKSARCSNK2A2CSNK2BCSNK2A1
SCHEMBL31632387 0.73 TNKS (0.53) TNKSARTERTCSNK2A2CSNK2B
SCHEMBL31632370 0.73 TNKS (0.56) TNKSARTERTCSNK2A2CSNK2B
SCHEMBL31632419 0.72 GABRP (0.51) TNKSCDK1CCNB1CSNK2A2CSNK2B
SCHEMBL31632539 0.70 CYP1B1 (0.45) TNKSCDK1CCNB1CSNK2A2CSNK2B
SCHEMBL31632312 0.70 AR (0.50) TNKSARTERTCSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025125811-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Ontrack Therapeutics Limited (GB) 2025-06-19 — — WO disclosed
Send feedback